Phase I Study to Determine the Pharmacokinetics, Pharmacodynamics, and Safety of IV Ganaxolone in Healthy Adults
Publication
, Conference
Tsai, J; Guptill, JT; MacLeod, DB; Husain, A; Patroneva, A
Published in: ANNALS OF NEUROLOGY
2016
Duke Scholars
Published In
ANNALS OF NEUROLOGY
EISSN
1531-8249
ISSN
0364-5134
Publication Date
2016
Volume
80
Start / End Page
S77 / S78
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Tsai, J., Guptill, J. T., MacLeod, D. B., Husain, A., & Patroneva, A. (2016). Phase I Study to Determine the Pharmacokinetics, Pharmacodynamics, and Safety of IV Ganaxolone in Healthy Adults. In ANNALS OF NEUROLOGY (Vol. 80, pp. S77–S78).
Tsai, Julia, Jeffrey T. Guptill, David B. MacLeod, Aatif Husain, and Albena Patroneva. “Phase I Study to Determine the Pharmacokinetics, Pharmacodynamics, and Safety of IV Ganaxolone in Healthy Adults.” In ANNALS OF NEUROLOGY, 80:S77–78, 2016.
Tsai J, Guptill JT, MacLeod DB, Husain A, Patroneva A. Phase I Study to Determine the Pharmacokinetics, Pharmacodynamics, and Safety of IV Ganaxolone in Healthy Adults. In: ANNALS OF NEUROLOGY. 2016. p. S77–8.
Tsai, Julia, et al. “Phase I Study to Determine the Pharmacokinetics, Pharmacodynamics, and Safety of IV Ganaxolone in Healthy Adults.” ANNALS OF NEUROLOGY, vol. 80, 2016, pp. S77–78.
Tsai J, Guptill JT, MacLeod DB, Husain A, Patroneva A. Phase I Study to Determine the Pharmacokinetics, Pharmacodynamics, and Safety of IV Ganaxolone in Healthy Adults. ANNALS OF NEUROLOGY. 2016. p. S77–S78.
Published In
ANNALS OF NEUROLOGY
EISSN
1531-8249
ISSN
0364-5134
Publication Date
2016
Volume
80
Start / End Page
S77 / S78
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences